June–July 2025: Wave of New FDA Approvals
From January to August 2025, the FDA approved 25 novel drugs – nearly one per week – reflecting an unprecedented pace in expanding treatment options across therapeutic areas
FDA Return
Leadership Shake-Up at the FDA Return of Dr. Vinay Prasad
Dr. Vinay Prasad, a hematologist-oncologist and outspoken critic of both FDA approval standards and public health policy, was appointed in May 2025 by Commissioner Marty Makary to lead CBER, the FDA division overseeing vaccines, gene therapies, and blood products